Search Results: depression (80)

Trail Blazers is a series of portraits by photographer Maria Levitov, spotlighting cannabis consumers from all walks of life.

Plenty of Denver residents like to blame the city’s influx of newcomers and rising real estate prices over the past few years on legal cannabis. Even if that were true, though, we can’t overlook all of the culture and innovation that pot has lured to the Mile High. Musician Nicholas Caputo, for example, recently moved here from Gainesville, Florida, “to pursue art and engage with cannabis culture.” He also wanted to treat his depression with cannabis.

The medicinal uses of marijuana span a wide variety of diseases and disorders, but a recent study conducted by Colorado State University indicates that cannabis may not be as useful for treating depression and anxiety.

In December 8, researchers in the Department of Psychology at Colorado State University published a study regarding the relationship between marijuana use and depression and anxiety in study participants. Led by professor Lucy Troup, a cognitive neuroscientist at CSU, the study focused on the residual effects of marijuana over time on three groups of students — casual users, chronic users and non-users — and observed how individuals assessed their levels of depression and anxiety.

The Arizona Department of Health Services again denied adding PTSD, depression, and migraines to the list of medical conditions that qualify people for a medical-marijuana card.
DHS Director Will Humble wrote on his blog that he “didn’t approve the petitions because of the lack of published data regarding the risks and benefits of using Cannabis to treat or provide relief for the petitioned conditions.” Phoenix New Times has the rest.

GrowMedical420.com

Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.
Worth Repeating
​By Ron Marczyk, R.N.
Health Education Teacher (Retired)
Lumír Ondřej Hanuš (left), discoverer of endogenous ligand, anandamide, from brain (1992) and Raphael Mechoulam (right), discoverer of psychoactive compound, (-)-trans-delta-9-tetrahydrocannabinol, from Cannabis sativa L. (1964). Both compounds bind to the CB1 and 2 cannabinoid receptors in the brain.
This post is dedicated to these two great medical researchers. The fathers of homeostatic cannabinoid based medicine:
 
Lumír Ondřej Hanuš, discoverer of the endogenous ligand, anandamide, from the brain (1992) and Raphael Mechoulam, discoverer of the psychoactive compound, THC, from Cannabis sativa (1964). Both compounds bind to the CB1 and 2 cannabinoid receptors in the brain.
These two men need to be nominated and awarded the 2012  Nobel Prize in medicine for discovering the healing potential of cannabis. Their discoveries will save the human race a great deal of suffering. Thank you for your gift to humanity, gentlemen.
Nobel ballots open this summer!

Trail Blazers is a series of portraits by photographer Maria Levitov, spotlighting cannabis consumers from all walks of life.

Kai Alexander moved to Colorado from North Dakota a little over a decade ago, eventually taking part in two of the state’s most notorious resources: craft beer and cannabis. A transgender and recent divorcé, Alexander now works for one of Aurora’s most popular breweries, using cannabis to help treat his longstanding anxiety and depression.

Ryan Kingsbury admits that he used to be that guy yelling at the TV during a football game, complaining that professional athletes were underperforming or overpaid. But after befriending a few of them and noticing a pattern of anxiety, depression and even suicidal thoughts once they left the game, he became familiar with the lonely corners in which former athletes sometimes find themselves.

“It’s much darker and uglier than we as a society want to admit,” Kingsbury says. “We [like to]cheer for them and root for them when they’re on the field — and then we couldn’t give two shits for them when they’re not.”

Every day millions of people battle with social and daily anxiety. It’s something more and more people are speaking up about, which is a strong and beautiful thing. Depression and anxiety is not to be ashamed of: It’s to be talked about.

Taking antidepressants is something I chose to do a few years ago, because medicine and therapy work. But I didn’t want to rely on pills such as Xanax for anxiety, so I looked elsewhere. The research in how marijuana affects mental health is extremely rare, but has picked up some traction recently as caretakers deal with troops suffering from post-traumatic stress disorder. We know of the many benefits cannabis has in regard to physical health, but could it have the same effect on the brain?

It’s part of a whole PR campaign.

Here’s your daily dose of pot news from the newsletter WeedWeek.

Ahead of his confirmation hearing for Attorney General, a public relations campaign is trying to depict Sen. Jeff Sessions as  emphatically not a racist. He has long been dogged by such accusations, due in part to a statement that he was ok with the Ku Klux Klan, until he heard that they smoke pot.

Rolling Stone envisions the war on drugs under Attorney General Sessions.

Oregon is  revising its product testing rules again, following complaints from companies. Nevada companies call for  strict product testing.

The Democrat and Chronicle (Rochester, N.Y.) reports on “ progress and hurdles” in the New York MED program. For more  see here.

Maine REC opponents  cancelled their recall effort. Gov. Paul LePage (R) said that with REC there’s no longer a need for a MED program. A prominent New Hampshire state senator  will propose a REC bill.

Canada.com looks at how legalization up north  could alter Canadian/American relations.

An Arizona judge ruled that local officials  can’t use federal law to block MED dispensaries.

The city of Copenhagen is pursuing a  longshot legalization push in an effort to reduce gang warfare.

Caribbean nation Dominica will  consider MED legalization next year.

Denver cannabis law firm Hoban Law Group  may sue the DEA over its recent CBD ruling.

Purdue Pharma, which makes Oxycontin, is  expanding overseas. In the U.S., the L.A. Times remarks, opioids are a “dying business.”

Hound Labs and Cannabix Technologies are  racing to perfect a cannabis breathalyzer.

Boston is another potential “ cannabis capital.” Canadian businesses are  preparing for legalization.

CBD pet treats are becoming big business.

Older adults are  using more cannabis, and binge drinking more too. Cannabis use  may not be a good idea for those seeking long-term abatement of depression and anxiety, Colorado researchers found.

Modern Farmer hangs out with  Bear Real, a Colorado hemp scientist.

1 2 3 8